Holen Sie sich die Stockscreener-App
1.94
2.65%
0.05
Handel nachbörslich:
1.90
-0.04
-2.06%
Schlusskurs vom Vortag:
$1.89
Offen:
$1.92
24-Stunden-Volumen:
39,997
Relative Volume:
0.35
Marktkapitalisierung:
$88.18M
Einnahmen:
$134.00K
Nettoeinkommen (Verlust:
$-9.93M
KGV:
-5.7059
EPS:
-0.34
Netto-Cashflow:
$-6.72M
1W Leistung:
-2.02%
1M Leistung:
+12.14%
6M Leistung:
-15.28%
1J Leistung:
+19.02%
1-Tages-Spanne:
$1.89
$1.94
1-Wochen-Bereich:
$1.76
$1.975
52-Wochen-Spanne:
$1.5006
$2.79
Entera Bio Ltd Stock (ENTX) Company Profile
Firmenname
Entera Bio Ltd
Sektor
Branche
Telefon
972-2-532-7151
Adresse
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Vergleichen Sie ENTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.94 | 85.90M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-22 | Eingeleitet | Aegis Capital | Buy |
Entera Bio Ltd Aktie (ENTX) Neueste Nachrichten
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress - MSN
Trend analysis for Entera Bio Ltd. this weekSwing Trade & Stock Market Timing Techniques - Newser
Is Entera Bio Ltd. showing signs of accumulationQuarterly Profit Summary & Detailed Earnings Play Strategies - Newser
Is it time to cut losses on Entera Bio Ltd.July 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Is Entera Bio Ltd. a defensive stockFree AI Stock Prediction Tool - thegnnews.com
What candlestick patterns are forming on Entera Bio Ltd.Low Exposure Strategy with Sector Analysis - Newser
Automated trading signals detected on Entera Bio Ltd.Real-Time AI Entry Forecast Generator - Newser
Is Entera Bio Ltd. stock reversal real or fakeTreasury Yields & Daily Profit Focused Screening - Newser
Why Entera Bio Ltd. stock attracts strong analyst attention2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - MSN
Is Entera Bio Ltd. meeting your algorithmic filter criteriaProfit Target Planning with Exit Confidence - Newser
Statistical indicators supporting Entera Bio Ltd.’s strengthEarly Entry Ideas with Momentum Potential - Newser
Ranking Entera Bio Ltd. among high performing stocks via toolsFree Weekly Top Gainers Forecast Watchlist - Newser
How moving averages guide Entera Bio Ltd. tradingFree Wealth Building Stock Market Ideas - Newser
What makes Entera Bio Ltd. stock price move sharplyCapital Protection Strategy With Risk Analysis - Newser
What MACD signals say about Entera Bio Ltd.Free High Accuracy Alerts for ROI Traders - Newser
How Entera Bio Ltd. stock performs during market volatilityWeekly Stock Picks with Trend Confidence - Newser
Using Bollinger Bands to evaluate Entera Bio Ltd.Quick Profit Setup with Signal Forecast - Newser
Entera Bio Second Quarter 2025 Earnings: US$0.057 loss per share (vs US$0.058 loss in 2Q 2024) - Yahoo Finance
Sentiment analysis tools applied to Entera Bio Ltd.Long-Term Investment Strategy Impact Analysis - Newser
Multi factor analysis applied to Entera Bio Ltd.Daily Market Movers Screener with Filters - Newser
What the charts say about Entera Bio Ltd. todayLow Risk Trade Timing with Analysis Metrics - Newser
Will Entera Bio Ltd. rebound enough to break evenFree Chart Driven High Reward Trading Setup - Newser
Entera Bio Beats Q2 EPS Estimates - The Motley Fool
Entera Bio Ltd. SEC 10-Q Report - TradingView
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Entera Bio Ltd expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Finanzdaten der Entera Bio Ltd-Aktie (ENTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):